Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-029353
Filing Date
2025-12-29
Accepted
2025-12-29 16:01:18
Documents
1
Period of Report
2025-12-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3449
  Complete submission text file 0001493152-25-029353.txt   4961
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address
Linscott Walt Addison (Reporting) CIK: 0001648585 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40652 | Film No.: 251609059

Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)